Author

Henri Montaudié

InsermORCID 0000-0002-0528-4829Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:metabolism & bioenergetics· 1 Assay:metabolomics· 1

Frequent Co-Authors

Ana Carolina Bastos Sant'Anna SilvaiD· 2 shared Caroline RobertiD· 2 shared Issam Ben‐SahraiD· 2 shared Michaël CerezoiD· 2 shared Patricia Abbe· 2 shared Stéphane RocchiiD· 2 shared Thierry PasseroniD· 2 shared Cyril RoncoiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Ana Carolina Bastos Sant'Anna SilvaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMar 18, 2026

Arginine synthesis pathway and ASS1 play a critical role in mRNA translation reprogramming and ICI resistance in cutaneous melanoma

Emilie Chessel, Wassila Khatir, Ana Carolina Bastos Sant'Anna Silva…·Michaël Cerezo

This study identifies arginine synthesis pathway and ASS1 as key factors in mRNA translation reprogramming and ICI resistance in cutaneous melanoma, showing that targeting ASS1 can restore sensitivity to anti-PD-1.

DOI 10.64898/2026.03.17.712479

humanmetabolomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintDec 31, 2025

MELK controls tumor metabolism to promote resistance to melanoma therapy

Ana Carolina Bastos Sant'Anna Silva, Patricia Abbe, Sophie Pagnotta…·Stéphane Rocchi

This study identifies MELK as a key driver of metabolic adaptation and therapy resistance in melanoma, showing that inhibiting MELK can sensitize resistant cells to immunotherapy.

DOI 10.64898/2025.12.31.697178

humanbulk RNA-seq

𝕏 PostBluesky